Review article: Clinical manifestations and outcomes of chronic nitrous oxide misuse: A systematic review

• Published in: Emergency medicine Australasia Vol. 34; no. 4; pp. 492 - 503
• Main Authors: Marsden, Pierce, Sharma, Aakriti A, Rotella, Joe‐Anthony
• Format: Journal Article
• Language: English
• Published: Melbourne Wiley Publishing Asia Pty Ltd 01.08.2022
• Subjects: drug misuse; Homocysteine - therapeutic use; Humans; Methylmalonic Acid - therapeutic use; nitrous oxide; Nitrous Oxide - adverse effects; Prospective Studies; subacute combined degeneration; vitamin B 12; Vitamin B 12 - therapeutic use; Vitamin B 12 Deficiency - complications; Vitamin B 12 Deficiency - diagnosis; Vitamin B 12 Deficiency - drug therapy; subacute combined degeneration; vitamin B 12; nitrous oxide; drug misuse
• ISSN: 1742-6731; 1742-6723; 1742-6723
• DOI: 10.1111/1742-6723.13997

Recreational nitrous oxide (N2O) use is widespread, and complications associated with its use are increasingly common. We sought to identify risk factors, clinical features and outcomes in individuals presenting with effects of chronic N2O abuse to develop an approach to clinical assessment and management. A systemic literature review was completed with searches conducted across EMBASE, MEDLINE, PSYCINFO and Cochrane databases. Our search strategy identified 612 studies, 105 met inclusion criteria, and 10 were added via hand search. Subjects from 24 case series and 91 case reports were typically in their 20s, using over 100 bulbs daily for several months. Neurological presentations, including sensory change, gait disturbance or weakness, were characteristic. Serum Vitamin B12 was normal or raised in 133 out of 243 case series subjects and 37 out of 84 reports. Serum homocysteine and methylmalonic acid were usually raised. Macrocytosis and anaemia were not commonly seen. MRI findings were abnormal with dorsal column change where specified, typically involving the cervical spine. Nerve conduction studies mostly reported a sensorimotor polyneuropathy. B12 replacement was the treatment of choice and partial recovery was most reported. This review highlights the dose‐dependent nature of chronic N2O toxicity and recognises functional B12 deficiency as the cause. As B12 is often normal, homocysteine and methylmalonic acid are important biomarkers of disease. An approach to diagnosis is offered but requires validation in prospective studies. Research exploring B12 and methionine therapy is required to refine management.